• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺功能比值保留但肺活量测定受损个体患肺癌风险增加:一项全国性队列研究

Increased risk of lung cancer in individuals with preserved ratio impaired spirometry: a nationwide cohort study.

作者信息

Kim Taeyun, Choe Junsu, Im Yunjoo, Heo Jihye, Park Hye Yun, Kang Danbee, Shin Sun Hye

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

Sci Rep. 2025 Jul 1;15(1):20663. doi: 10.1038/s41598-025-05972-4.

DOI:10.1038/s41598-025-05972-4
PMID:40594569
Abstract

Accumulating data showed that individuals with preserved ratio impaired spirometry (PRISm) have an increased risk for all-cause mortality and respiratory-related mortality compared with normal spirometry. However, the association between PRISm and lung cancer development is not known. A retrospective cohort study was conducted using the Korean National Health and Nutrition Examination Survey data between 2007 and 2017, which was linked to the Health Insurance Review and Assessment database from 2007 to 2021. Men and women aged 40 to 79 years were categorized by baseline spirometry; PRISm (FEV/FVC ≥ 0.7 and FEV < 80% pred), COPD (FEV/FVC < 0.7) and normal spirometry (FEV/FVC ≥ 0.7 and both FEV and FVC ≥ 80% pred). Incident lung cancer was defined as the presence of the International Classification of Diseases-10 C33 or C34 code. Among 26,490 individuals, 2628 (9.9%) and 3811 (14.4%) had PRISm and COPD, respectively. Compared to those with normal spirometry, those with PRISm were more likely female (72.0%) and never-smokers (70.2%). During the median follow-up of 10 years, individuals with PRISm (fully-adjusted HR = 1.83, 95% CI 1.25, 2.66) and COPD (fully-adjusted HR = 2.91, 95% CI 2.23, 3.80) had significantly higher risk of lung cancer than those with normal spirometry. The association between PRISm and lung cancer was more evident in ever smokers. This nationwide cohort study revealed that PRISm might be an independent risk factor for lung cancer development.

摘要

越来越多的数据表明,与肺功能正常的个体相比,肺功能测定比率保留受损(PRISm)的个体全因死亡率和呼吸相关死亡率风险增加。然而,PRISm与肺癌发生之间的关联尚不清楚。利用2007年至2017年韩国国家健康与营养检查调查数据进行了一项回顾性队列研究,该数据与2007年至2021年的健康保险审查与评估数据库相关联。40至79岁的男性和女性根据基线肺功能测定进行分类;PRISm(FEV/FVC≥0.7且FEV<预测值的80%)、慢性阻塞性肺疾病(COPD,FEV/FVC<0.7)和肺功能正常(FEV/FVC≥0.7且FEV和FVC均≥预测值的80%)。新发肺癌定义为存在国际疾病分类第10版C33或C34编码。在26490名个体中,分别有2628名(9.9%)和3811名(14.4%)患有PRISm和COPD。与肺功能正常的个体相比,患有PRISm的个体女性比例更高(72.0%)且从不吸烟者比例更高(70.2%)。在10年的中位随访期间,患有PRISm(完全调整后的HR=1.83,95%CI为1.25,2.66)和COPD(完全调整后的HR=2.91,95%CI为2.23,3.80)的个体患肺癌的风险显著高于肺功能正常的个体。PRISm与肺癌之间的关联在曾经吸烟者中更为明显。这项全国性队列研究表明,PRISm可能是肺癌发生的一个独立危险因素。

相似文献

1
Increased risk of lung cancer in individuals with preserved ratio impaired spirometry: a nationwide cohort study.肺功能比值保留但肺活量测定受损个体患肺癌风险增加:一项全国性队列研究
Sci Rep. 2025 Jul 1;15(1):20663. doi: 10.1038/s41598-025-05972-4.
2
A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的多维诊断方法
JAMA. 2025 May 18. doi: 10.1001/jama.2025.7358.
3
Incidence and Risk Factors of Tuberculosis-Associated Chronic Obstructive Pulmonary Disease.结核病相关慢性阻塞性肺疾病的发病率及危险因素
Int J Chron Obstruct Pulmon Dis. 2025 Jun 26;20:2091-2102. doi: 10.2147/COPD.S523732. eCollection 2025.
4
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
5
Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma.对所有严重程度哮喘中肺功能测定表型受损的保留率进行特征描述。
Respir Med. 2025 Aug;244:108180. doi: 10.1016/j.rmed.2025.108180. Epub 2025 May 27.
6
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
7
Longitudinal association between hemoglobin and lung function with insights into the incidence of airflow obstruction: an observational study.血红蛋白与肺功能的纵向关联及对气流阻塞发生率的洞察:一项观察性研究
BMC Pulm Med. 2025 Jan 30;25(1):50. doi: 10.1186/s12890-025-03505-3.
8
General population-based lung function trajectories over the life course: an accelerated cohort study.基于一般人群的终生肺功能轨迹:一项加速队列研究。
Lancet Respir Med. 2025 Jul;13(7):611-622. doi: 10.1016/S2213-2600(25)00043-8. Epub 2025 May 15.
9
Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).溴化乌美溴铵对比安慰剂用于慢性阻塞性肺疾病(COPD)患者。
Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD011897. doi: 10.1002/14651858.CD011897.pub2.
10
[Comparison of lung function and inflammatory markers and analysis of risk factors for acute exacerbations in patients with chronic obstructive pulmonary disease and persistent airflow limitation asthma].[慢性阻塞性肺疾病和持续性气流受限哮喘患者肺功能与炎症标志物的比较及急性加重危险因素分析]
Zhonghua Yi Xue Za Zhi. 2025 Jun 24;105(24):1981-1988. doi: 10.3760/cma.j.cn112137-20250208-00278.

本文引用的文献

1
Activin A as a potential biomarker for preserved ratio impaired spirometry (PRISm) and clinical outcomes in community-dwelling adults.激活素 A 作为一个潜在的生物标志物,用于预测社区居住成年人中比值保留型肺量计受损(PRISm)和临床结局。
Arch Gerontol Geriatr. 2024 Nov;126:105539. doi: 10.1016/j.archger.2024.105539. Epub 2024 Jun 17.
2
The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.美国 NHANES 2007-2012 年中 PRISm 和 COPD 的流行率和死亡率风险。
Respir Res. 2024 May 15;25(1):208. doi: 10.1186/s12931-024-02841-y.
3
Association of Metabolic Syndrome With Risk of Lung Cancer: A Population-Based Prospective Cohort Study.
代谢综合征与肺癌风险的关联:一项基于人群的前瞻性队列研究。
Chest. 2024 Jan;165(1):213-223. doi: 10.1016/j.chest.2023.08.003. Epub 2023 Aug 10.
4
Longitudinal Changes and Association of Respiratory Symptoms with Preserved Ratio Impaired Spirometry (PRISm): The Nagahama Study.纵向变化以及呼吸症状与肺量计测定比值正常但存在气流受限(PRISm)的关联:长滨研究
Ann Am Thorac Soc. 2023 Nov;20(11):1578-1586. doi: 10.1513/AnnalsATS.202301-050OC.
5
Trajectories of Spirometric Patterns, Obstructive and PRISm, in a Population-Based Cohort in Latin America.在拉丁美洲的一个基于人群的队列中,肺量计模式、阻塞和 PRISm 的轨迹。
Int J Chron Obstruct Pulmon Dis. 2023 Jun 21;18:1277-1285. doi: 10.2147/COPD.S406208. eCollection 2023.
6
Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort.中年亚洲队列中,保存比值受损的肺量计纵向死亡率。
BMC Pulm Med. 2023 May 3;23(1):155. doi: 10.1186/s12890-023-02451-2.
7
Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study.肺功能障碍和 COPD 增加心血管疾病风险:加拿大队列研究。
Chest. 2023 Sep;164(3):637-649. doi: 10.1016/j.chest.2023.02.045. Epub 2023 Mar 4.
8
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.全球慢性阻塞性肺疾病倡议 2023 年报告:GOLD 执行摘要。
Eur Respir J. 2023 Apr 1;61(4). doi: 10.1183/13993003.00239-2023. Print 2023 Apr.
9
Preserved ratio impaired spirometry with or without restrictive spirometric abnormality.无论是否存在限制性肺量计异常,肺量计的比值都受到了影响。
Sci Rep. 2023 Feb 20;13(1):2988. doi: 10.1038/s41598-023-29922-0.
10
Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.德国肺癌筛查干预研究(LUSI)中的肺功能损害:患病率、症状以及与肺癌风险、肿瘤组织学和全因死亡率的关联
Transl Lung Cancer Res. 2022 Sep;11(9):1896-1911. doi: 10.21037/tlcr-22-63.